Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-004624

Chief Financial Officer sold 81,875 shares at $14.55 ($1,191,281)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Myszkowski Kenneth Allen Chief Financial Officer 2019-01-17 Sale −81,875 $14.55 $1,191,281 305,607 D: show line 1 in the form
Open-market sales · 81,875 sh · avg $14.55 · $1,191,281
Loading xslF345X03/doc4.xml…